Nutex Health (NUTX) Capital Expenditures (2011 - 2026)

Nutex Health has disclosed Capital Expenditures across 13 years of filings, most recently posting $1.2 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $1.2 million, up 1776.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 124.04% YoY), and the FY2025 annual result was $2.5 million, up 9.64% from the prior year.
• Capital Expenditures came in at $1.2 million for Q1 2026 at Nutex Health, down from $1.4 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $8.6 million in Q1 2022 to a low of -$7.9 million in Q4 2022.
• The 5-year median for Capital Expenditures is $751000.0 (2025), against an average of $1.8 million.
• Across the five-year window, Capital Expenditures slumped 167.23% in 2022 and jumped 1776.56% in 2026, its largest moves.
• Nutex Health's Capital Expenditures stood at -$7.9 million in 2022, then soared by 89.52% to -$825487.0 in 2023, then jumped by 147.85% to $395000.0 in 2024, then soared by 256.71% to $1.4 million in 2025, then retreated by 14.76% to $1.2 million in 2026.
• The last three Capital Expenditures figures came in at $1.2 million (Q1 2026), $1.4 million (Q4 2025), and $302000.0 (Q3 2025), per Business Quant data.